GS News 174.03 08/21/2014 05:14:54 Goldman Sachs Group (GS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Goldman Sachs Group (GS) 174.03 $GS

Goldman Halts Efforts to End $1B Libya Fund Lawsuit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 20, 5:26PM CDT
The Goldman Sachs Group, Inc. (GS) stopped its attempt to dispose a $1billion lawsuit filed by the Libyan Investment Authority (LIA), a sovereign wealth fund at London's High Court.

'Wrap Fee' Accounts of Financial Advisors Under SEC Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 20, 5:15PM CDT
'Wrap fee' accounts of the investment advisory and brokerage firms have recently come under the scanner of the U.S. Securities and Exchange Commission (SEC).

Investment Bank Stock Showdown: Morgan Stanley or Goldman Sachs? - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Wed Aug 20, 11:37AM CDT
Taking a closer look at Morgan Stanley vs. Goldman Sachs, which is the better investment?

Banks' Living Wills No More Includes Discount Lending Window - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 20, 11:00AM CDT
The news that the Fed's discount lending window (that offers reliable source of funding to banks in case of liquidity crunch) can no more be a part of their 'Living Will' assumptions, came as a blow to the major global banks.

Upcoming Earnings, Opening of a New Lounge, Appointments, Survey Results and Updates on Discussions - Research Reports on Visa, Goldman Sachs, American Express, AvalonBay and Zillow
PR Newswire - Wed Aug 20, 8:00AM CDT
Today, Analysts Review released its research reports regarding Visa Inc. (NYSE: V), The Goldman Sachs Group Inc (NYSE: GS), American Express Company (NYSE: AXP), AvalonBay Communities Inc. (NYSE: AVB) and Zillow Inc. (NASDAQ: Z). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5853-100free.

Dow Today: Chevron (CVX) Leads The Day Higher, Goldman Sachs Group (GS) Lags
at The Street - Tue Aug 19, 3:30PM CDT
The Dow component that led the way higher today was Chevron (NYSE:CVX), which sported a $1.33 gain (+1.1%) bringing the stock to $127.63. Holding the Dow back today was Goldman Sachs Group (NYSE:GS), which lagged the broader Dow index with a 59-cent...

Sycamore Shops Stuart Weitzman
at The Street - Tue Aug 19, 10:26AM CDT
Taps Goldman and Citigroup to run auction for the upscale footwear retailer it acquired in its $2.2 billion deal for Jones Group.

Clinton's Wild Idea for Bank Fines Makes Perfect Sense
at The Street - Tue Aug 19, 6:30AM CDT
Former President Clinton's proposal to spend money from bank fines on infrastructure has been widely ignored. But it may help Americans feel the fines are serving a real purpose.

Steel, Airline Stocks Lead As Nasdaq Hits High
at Investor's Business Daily - Mon Aug 18, 3:32PM CDT
Stocks advanced confidently Monday as the Nasdaq struck a new 52-week high and the S&P 500 retook its 50-day moving average. The Nasdaq strode more than 0.9% higher, while the S&P 500 added almost 0.9%. The Dow Jones industrial average led with a...

Blackstone, TPG in Talks to Buy Mortgage-Lender Kensinton - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 3:10PM CDT
Negotiations have advanced between Blackstone and TPG Capital, regarding the purchase of U.K.'s sub-prime mortgage lender, Kensinton, from its South African parent company, Investec. The news was first reported by Sky News.

3 Reasons Goldman Sachs’ Stock Could Rise
Matthew Frankel, The Motley Fool - Motley Fool - Mon Aug 18, 2:45PM CDT
Goldman Sachs has a reputation for being "the smartest guys on Wall Street", and Warren Buffett himself has even gone so far as to refer to an investment in Goldman Sachs as "a bet on brains." However, Goldman has lagged the overall market over...

Why Procter & Gamble (PG) Stock Is Up Today
at The Street - Mon Aug 18, 12:49PM CDT
Duracell batteries and Braun shavers are reportedly the two largest company assets likely to be divested.

Dollar General Climbs Atop Dollar Tree
at The Street - Mon Aug 18, 11:10AM CDT
Bests proposal for Family Dollar with $78.50 per share offer that values target at $9.6 billion, including debt.

5 Rocket Stocks to Buy for Gains This Week
at The Street - Mon Aug 18, 10:43AM CDT
These stocks have both short-term gain catalysts and longer-term growth prospects.

Can Goldman Sachs' Women Make the Cut in 'Extreme Jobs?'
at The Street - Mon Aug 18, 10:27AM CDT
An expert for Goldman Sachs & Co. says it's possible that women don't make as much as the men do because they don't do as well at 'extreme jobs.'

Warren Buffett's Top 25 Stocks for 2014
at The Street - Mon Aug 18, 9:29AM CDT
These are Berkshire Hathaway's (BRK.A) 25 largest holdings.

Warren Buffett's Top 10 Dividend Stocks
at The Street - Mon Aug 18, 8:20AM CDT
Here are 10 of the top dividend stock holdings in Warren Buffett's Berkshire Hathaway portfolio.

How Will NXP Semiconductors (NXPI) Stock Be Affected Today By This Downgrade?
at The Street - Mon Aug 18, 6:53AM CDT
Shares of NXP Semiconductors (NXPI) are down after the semiconductor company was downgraded to 'sell' from 'neutral' at 'Goldman Sachs Group (GS).

GE Restarts Auction for Appliance Business
at The Street - Thu Aug 14, 2:41PM CDT
Conglomerate confirms talks with Sweden's Electrolux as reports point a joint bid by Quirky and Blackstone.

Stock Market News for August 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 9:10AM CDT
Benchmarks ended in the green as gains in biotech stocks offset discouraging retail sales numbers
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Copper Peptides Shine in New Renue Blue Cream

Updated Category News Views 171

Renue By Science's Ambitious Skincare Launch Alright, we've got a big player stepping up in the realm of skincare with a new face cream packed tightly with science-backed goodies. Renue By Science is revamping their game by anchoring their new Renue Blue Face Cream around the star of the moment: copper tripeptide-1, also known as GHK-Cu. This is more than a beauty gloss...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 156

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 136

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 81

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 72

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 108

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 118

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Natural Hydrogen: MAX Power Mining's Vision

Updated Category News Views 184

MAX Power Mining Corp. Driving Innovation in Natural Hydrogen In an era where energy demands are escalating, especially with the rise of artificial intelligence and advanced technologies, the search for sustainable power sources has reached new heights. Enter MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX), a trailblazer in the natural hydrogen sector, demonstrating...

Continue Reading
Inland Empire Health Plan Achieves Excellence in GIS Recognition

Updated Category News Views 246

A Celebration of Achievement for Inland Empire Health Plan Inland Empire Health Plan (IEHP) has achieved remarkable recognition by winning its third Special Achievement in GIS (SAG) award from Esri, the global leader in Geographic Information System (GIS) technology. This prestigious accolade highlights IEHP's commitment to utilizing innovative technology to enhance...

Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge

Updated Category News Views 226

Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...

Continue Reading
Future Landscape of the UV Stabilizers Market by 2032

Updated Category News Views 176

Growth of the UV Stabilizers Market The UV stabilizers market is gaining momentum, projected to expand from USD 1.4 billion to USD 2.3 billion by 2032, with a compound annual growth rate (CAGR) of 5.5% during the 2024-2032 period. This growth is fueled by the increasing demand for materials that are durable and can endure the degrading effects of ultraviolet (UV)...

Continue Reading
Dr. Rushika Fernandopulle Joins Premera Board of Directors

Updated Category News Views 337

Dr. Rushika Fernandopulle Joins Premera's Board Premera Blue Cross is excited to announce the addition of Dr. Rushika Fernandopulle to its Board of Directors. This decision is part of a strategic effort to strengthen leadership and expertise within the organization. Dr. Fernandopulle takes over from Dr. John Jenrette, who has completed his term this year. Expertise and...

Continue Reading